Rhythm Biosciences Ltd (ASX: RHY) Completes Genetype Acquisition
Rhythm Biosciences Ltd completes the acquisition of Genetype assets, enhancing its cancer diagnostics portfolio.
The Hub of Australian Finance News
Rhythm Biosciences Ltd completes the acquisition of Genetype assets, enhancing its cancer diagnostics portfolio.
29Metals Limited (ASX:29M) completes its retail entitlement offer, raising $26 million to support business initiatives.
Acta Investment Group announces a proportional takeover offer for Helix Resources Limited, aiming for 25% of shares.
Helix Resources Limited (ASX: HLX) updates shareholders to accept Acta’s takeover offer following a new implementation agreement.
Helix Resources Ltd (ASX:HLX) enters an Implementation Agreement with Acta, reducing takeover offer conditions and enhancing capital and shareholder value.
Imugene Limited (ASX:IMU) raises up to A$46 million through a new funding initiative to support its clinical trial pipeline.
Tivan Limited confirms compliance with ASX Listing Rules following $7.4 million grant announcement.
Cazaly Resources Limited reports promising drilling results from the Kaoko lithium project, indicating elevated lithium mineralisation.
Regional Express Holdings Ltd has successfully completed the sale of its Pel-Air ambulance business to Toll Holdings Ltd, directing proceeds to debt repayment.
Maxo Telecommunications has extended its takeover offer period for Vonex Limited to 20 January 2025.